Table 1

Patient data for the historical “no STS” control group1-a

PatientAge/SexDiagnosisNo. of BBBD with carboplatinPrior ChemotherapyPrior RTNoise Hx
126 /MGBM4NoNoN/A
221 /FGBM21NoNoNo
316 /FPNET25Cisplatin, etoposideNoNo
460 /MMetastatic cancer20NoNoN/A
58 /MPNET18NoNoNo
631 /MGBM8NoNoNo
751 /FMetastatic cancer6Cyclophosphamide, ARA-C, i.p. cisplatin for five coursesNoNo
849 /MGBM6NoNoYes
930 /MGBM15NoNoYes
1063 /FPCNSL11Intraocular donorubucinIntra-BBB Ocular RTNo
1129 /MPNET24NoNoNo
1219 /FPNET23Carboplatin, BCNU, StreptozotocinYesNo
1330 /FPNET23NoNoNo
1449 /MBrainstem glioma10NoIntra-BBBYes
1523 /MGerminoma21Cisplatin for two coursesNoNo
1667 /MMetastatic cancer5Cisplatin for six coursesYesYes
1723 /FPNET15NoNoNo
1852 /MPNET12NoNoYes
1963 /FMetastatic cancer4Cisplatin for six coursesNoNo
  • 1-a GBM, glioblastoma multiforme; N/A, not available; PCNSL, primary central nervous system lymphoma; PNET, primitive neuroectodermal tumor; RT, radiation therapy.